Transthyretin cardiac amyloidosis
Clinical trials for Transthyretin cardiac amyloidosis explained in plain language.
Never miss a new study
Get alerted when new Transthyretin cardiac amyloidosis trials appear
Sign up with your email to follow new studies for Transthyretin cardiac amyloidosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New PET scan could spot hidden heart disease
Diagnosis Not yet recruitingThis study tests whether a special PET-CT scan using a drug called evuzamitide can detect signs of cardiac amyloidosis in people whose standard heart scans were unclear but who have high levels of a blood marker called TAD1. About 25 adults with heart failure or a genetic risk fo…
Matched conditions: TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Sponsor: Lorena Saelices • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
New heart scan could speed up amyloidosis diagnosis
Diagnosis Not yet recruitingThis study will test whether a faster type of bone scan (CZT-SPECT) can accurately diagnose transthyretin cardiac amyloidosis, a serious heart condition. Researchers will compare the new scan with the standard method in 200 patients. If it works, it could make diagnosis quicker a…
Matched conditions: TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
AI spots heart clues in bone scans: a new way to catch a silent killer?
Diagnosis Not yet recruitingThis study tests whether a computer model can find signs of a heart condition called cardiac amyloidosis in bone scans that were done for other reasons. Researchers will look back at 57 patients' scans to see if the model can correctly identify those with the disease. If it works…
Matched conditions: TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Sponsor: University Hospital, Lille • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Heart rehab hope for rare amyloidosis patients
Symptom relief Not yet recruitingThis study tests whether a structured 5-week cardiac rehabilitation program can improve exercise ability and quality of life in 40 adults with cardiac amyloidosis. Participants will undergo supervised aerobic and strength training five days a week, with tests before and after the…
Matched conditions: TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Home workouts and shakes aim to boost strength in heart disease patients
Symptom relief Not yet recruitingThis study tests whether a home-based exercise program combined with nutritional supplements can improve walking ability and muscle strength in people aged 70 and older with transthyretin cardiac amyloidosis, a heart condition that causes weakness and frailty. About 102 participa…
Matched conditions: TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Sponsor: Universidad de Burgos • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC